Dr. Reddy's Laboratories Files Form 6-K

Ticker: RDY · Form: 6-K · Filed: Aug 12, 2024 · CIK: 1135951

Sentiment: neutral

Topics: sec-filing, compliance, foreign-private-issuer

TL;DR

DRL filed a 6-K, standard compliance update. Nothing new for traders.

AI Summary

Dr. Reddy's Laboratories Ltd. filed a Form 6-K on August 12, 2024, to report information as a foreign private issuer. The filing includes standard corporate information and confirms the company's adherence to filing requirements, such as submitting annual reports under Form 20-F.

Why It Matters

This filing is a routine update for investors and regulatory bodies, confirming Dr. Reddy's compliance with SEC reporting obligations as a foreign private issuer.

Risk Assessment

Risk Level: low — This is a routine administrative filing by Dr. Reddy's Laboratories Ltd. and does not contain new material financial or operational information.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information to the SEC that the issuer has made or is required to make public in its home country.

What is the filing date of this Form 6-K?

The filing date of this Form 6-K is August 12, 2024.

Which annual report form does Dr. Reddy's Laboratories Ltd. indicate it files?

Dr. Reddy's Laboratories Ltd. indicates it files annual reports under cover of Form 20-F.

Where are Dr. Reddy's Laboratories Ltd.'s principal executive offices located?

Dr. Reddy's Laboratories Ltd.'s principal executive offices are located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana, 500 034, India.

What is the SIC code for Dr. Reddy's Laboratories Ltd.?

The Standard Industrial Classification (SIC) code for Dr. Reddy's Laboratories Ltd. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 402 words · 2 min read · ~1 pages · Grade level 16.7 · Accepted 2024-08-12 06:15:48

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: August 12, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing